Circulating free (cf) DNA testing in lung cancer
Lung Cancer EGFR circulating tumour DNA (cfDNA) ctDNA
PURPOSE OF PROGRAMME:
cfDNA testing for EGFR hotspot mutations in lung cancer.
MATERIAL PROVIDED: Plasma: artificial
DISTRIBUTIONS PER YEAR: 1
SAMPLES PER DISTRIBUTION: 3
FREQUENCY OF DISTRIBUTION: 1
PROGRAMME OF ANALYSIS:
circulating tumour DNA variant hotspots in EGFR
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA